HuMOLYTE Launches Patient Experience Survey for Chemotherapy Support
The Californer/10313771

SACRAMENTO, Calif. - Californer -- HuMOLYTE, a medical food designed to support patients undergoing chemotherapy, today announced the launch of its Patient Experience Survey, aimed at gathering real-world feedback from individuals preparing to begin chemotherapy. This initiative offers selected participants access to HuMOLYTE at no cost in exchange for their experience and insights.

HuMOLYTE is GRAS (Generally Recognized as Safe) and formulated to help alleviate common chemotherapy-related side effects, including vomiting, diarrhea, and mouth sores, by supporting hydration, electrolyte balance, and mucosal health. In addition to ongoing formal clinical trials, the Patient Experience Survey will help the HuMOLYTE team better understand patient needs and refine product use.

"While clinical data is critical, patient voices are equally valuable in helping us improve HuMOLYTE and better serve the oncology community," said Dr. Sourabh Kharait, CEO at IGH Naturals, "This survey allows us to collect feedback from individuals actively going through chemotherapy and ensure we're addressing real-world challenges."

More on The Californer

• Dedeaux inks global logistics firm to long-term lease for newly built warehouse in Fontana, CA
• iRobot Corporation (IRBT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
• Swim Up Hill, Diversity in Aquatics, and Inglewood Host Movie Night Celebrating Aquatic Equity
• Macon's Historic Douglass Theatre Names Toni Simmons Henson as Artistic Director for Inaugural Series Celebrating the Spirit of American Theatre
• LACI Presents Reframe Systems with $25,000 Grand Prize for LA Resilient Rebuilding Cup; Prize Funding to Support Innovation Pilots Including to Reduce Cost, Time to Rebuild Resilient and Sustainable Homes in Fire-Affected Communities in Greater Los Angele

Survey Participation Details:

• Eligibility: Individuals preparing to start chemotherapy.
• What's Provided: Selected participants will receive HuMOLYTE at no cost for one chemotherapy cycle.
• Expectation: Follow the recommended protocol and complete a brief post-treatment survey.
• Purpose: Feedback will be used for product development and quality improvement.

HuMOLYTE is developed for use under physician supervision and is not intended to diagnose, treat, cure, or prevent any disease.

About HuMOLYTE

HuMOLYTE is a medical food specifically formulated to support individuals undergoing chemotherapy by promoting hydration, electrolyte balance, and mucosal health. Backed by scientific research and developed to address common gastrointestinal side effects, HuMOLYTE is currently undergoing human clinical trials.

Apply for the Survey

Interested individuals can learn more and apply for the Patient Experience Survey at:

https://www.humolyte.com/blog/join-the-humolyte-chemotherapy-patient-experience-survey-apply-for-a-free-supply